| Sample | Title | Value | Rank |
|---|
| GSM16943 | Wild Type Control Set A | 15.2 | 33 |
| GSM18491 | WT Control Sample B | 18.6 | 39 |
| GSM18492 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A | 22.2 | 39 |
| GSM18493 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B | 7.1 | 22 |
| GSM18494 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A | 29 | 42 |
| GSM18495 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B | 18.3 | 38 |
| GSM18496 | MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A | 16.7 | 31 |
| GSM18497 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B | 5.3 | 21 |
| GSM18498 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A | 3.4 | 6 |
| GSM18499 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B | 1.4 | 4 |
| GSM18500 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A | 14.8 | 28 |
| GSM18501 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B | 6.1 | 21 |